Chemoimmunotherapy for Triple-Negative Breast Cancer

被引：2
|
作者：
Slomski, Anita
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 24期
关键词：
D O I：
10.1001/jama.2018.20159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2521 / 2521
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [32] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [33] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [34] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204
  • [35] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [36] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [37] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269
  • [38] Triple-negative breast cancer in the elderly
    Shagisultanova, Elena
    Mayordomo, Jose
    Elias, Anthony D.
    BREAST JOURNAL, 2017, 23 (06): : 627 - 629
  • [39] Characteristics of triple-negative breast cancer
    Tim C. de Ruijter
    Jürgen Veeck
    Joep P. J. de Hoon
    Manon van Engeland
    Vivianne C. Tjan-Heijnen
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 183 - 192
  • [40] Pharmacotherapy of triple-negative breast cancer
    Arslan, Cagatay
    Dizdar, Omer
    Altundag, Kadri
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2081 - 2093
12345